# Exploring AC1903 | TRP/TRPV Channel | TargetMol the Technical Profile and Research Applications of AC1903 Peptide
In the specialized field of biochemical research, identifying precise tools for protein modulation is essential. Among the reagents f AC 1903 : ≥98% (HPLC). Background References References are publications that support the biological activity of the product. … requently discussed in laboratory circles, the AC1903 peptide (often categorized as a small-molecule inhibitor) has gained significant traction. As a researcher focused on ion channel dynamics, I have found that understanding the CAS-registered characteristics of this compound provides vital insights into its role as a selective TRPC5 inhibitor.
The nomenclature surrounding these compounds can be dense, but focusing on the specific entity is key. AC1903 is formally recognized by the CAS number 831234-13-0. From a structural perspective, it is a furan-bearing benzimidazole scaffold, often characterized by a high degree of purity (frequently ≥98% as verified by HPLC).
When reviewing data sheets from suppliers like Cayman Chemical or MedChemExpress, one quickly notices its specificity toward the Transient Receptor Potential Canonical 5 (TRPC5) channels. Unlike broader approaches that might affect other channels, AC1903 serves as a targeted tool, often demonstrati Design, synthesis and characterization of novel N-heterocyclic-1 … ng minimal secondary effects on related channels like TRPC4. For those interested in TRPC5 channel inhibition, its efficacy is often defined by its IC50 value, which typically falls within the range of 4 µM to 14.7 µM, depending on the specific cellular assay employed.
Integrating AC1903 into Research Workflows
My personal experience with utilizing AC1903 involves investigating non-selective cation channel pathways. When navigating the search intent of researchers looking for AC1903 mechanism of action or AC1903 synthesis, it is crucial to recognize that this molecule acts as a block May 12, 2022 · The furan bearing benzimidazole compound AC1903, 1, played a significant role in establishing that TRPC5 inhibition … er of riluzole-activated AC 1903 : ≥98% (HPLC). Background References References are publications that support the biological activity of the product. … TRPC5 currents.
In my laboratory setup, I prioritize the following verifiable parameters:
* Molecular Specificity: It effectively suppresses TRPC5-mediated ion flux.
* Stability: When stored according to technical guidelines (usually a AC1903 (30 µM) inhibits angiotensin II-induced production of reactive oxygen species (ROS) in wild-type podocytes and podocytes … t -20°C in a dry environment), the compound maintains excellent structural integrity.
* Biological Activity: Its application contributes significantly to studies involving podocyte-protective properties and the downstream effects of blocking angiotensin II-induced reactive oxygen species (ROS) in various cell models.
Evaluating LSI and Related Technical Contexts
When discussing AC1903, it is impossible to ignore the broader context of TRP channel inhibitors. Variations such as "TRPC5 blocker" or "benzimidazole-based inhibitors" are frequently used in scientific literature. Whether evaluating AC1903 research applications or investigating the potential impacts on proteinuria and podocyte loss, the compound remains a cornerstone for those studying Calcium-permeable channels.
Interestingly, some investigations extend beyond simple inhibition. Recent stu Nonselective TRPC channel inhibition and suppression of … dies have touched upon its capacity to suppress aminoglycoside-induced premature termination codon readthrough. This reflects the multifactorial potential of small molecules when applied in controlled laboratory environments.
Best Practices and Experimental Vigilance
For AC1903: A Comprehensive Technical Guide to its Therapeutic … those planning to integrate this reagent into their experimental design, several considerations are paramount. Always refer to the provided technical documentation regarding AC1903 CAS 831234-13-0 to ensure the chemical identity matches your specific research intent. Given the potency of this compound, titration experiments are recommended to establish the optimal concentration for your specific model system—balancing efficacy with the need to avoid potential off-target toxicities.
The field of ion channel research continues to evolve, and compounds like AC1903 provide the precise, targeted control necessary to map the complex landscape of transient receptor potential channels. By adhering to rigorous experimental standards and sourcing from established suppliers, one can reliably utilize these tools to generate meaningful, reproducible data in a dedicated laboratory setting.
# Exploring AC1903 | TRP/TRPV Channel | TargetMol the Technical Profile and Research Applications of AC1903 Peptide
In the specialized field of biochemical research, identifying precise tools for protein modulation is essential. Among the reagents f AC 1903 : ≥98% (HPLC). Background References References are publications that support the biological activity of the product. … requently discussed in laboratory circles, the AC1903 peptide (often categorized as a small-molecule inhibitor) has gained significant traction. As a researcher focused on ion channel dynamics, I have found that understanding the CAS-registered characteristics of this compound provides vital insights into its role as a selective TRPC5 inhibitor.
The nomenclature surrounding these compounds can be dense, but focusing on the specific entity is key. AC1903 is formally recognized by the CAS number 831234-13-0. From a structural perspective, it is a furan-bearing benzimidazole scaffold, often characterized by a high degree of purity (frequently ≥98% as verified by HPLC).
When reviewing data sheets from suppliers like Cayman Chemical or MedChemExpress, one quickly notices its specificity toward the Transient Receptor Potential Canonical 5 (TRPC5) channels. Unlike broader approaches that might affect other channels, AC1903 serves as a targeted tool, often demonstrati Design, synthesis and characterization of novel N-heterocyclic-1 … ng minimal secondary effects on related channels like TRPC4. For those interested in TRPC5 channel inhibition, its efficacy is often defined by its IC50 value, which typically falls within the range of 4 µM to 14.7 µM, depending on the specific cellular assay employed.
Integrating AC1903 into Research Workflows
My personal experience with utilizing AC1903 involves investigating non-selective cation channel pathways. When navigating the search intent of researchers looking for AC1903 mechanism of action or AC1903 synthesis, it is crucial to recognize that this molecule acts as a block May 12, 2022 · The furan bearing benzimidazole compound AC1903, 1, played a significant role in establishing that TRPC5 inhibition … er of riluzole-activated AC 1903 : ≥98% (HPLC). Background References References are publications that support the biological activity of the product. … TRPC5 currents.
In my laboratory setup, I prioritize the following verifiable parameters:
* Molecular Specificity: It effectively suppresses TRPC5-mediated ion flux.
* Stability: When stored according to technical guidelines (usually a AC1903 (30 µM) inhibits angiotensin II-induced production of reactive oxygen species (ROS) in wild-type podocytes and podocytes … t -20°C in a dry environment), the compound maintains excellent structural integrity.
* Biological Activity: Its application contributes significantly to studies involving podocyte-protective properties and the downstream effects of blocking angiotensin II-induced reactive oxygen species (ROS) in various cell models.
Evaluating LSI and Related Technical Contexts
When discussing AC1903, it is impossible to ignore the broader context of TRP channel inhibitors. Variations such as "TRPC5 blocker" or "benzimidazole-based inhibitors" are frequently used in scientific literature. Whether evaluating AC1903 research applications or investigating the potential impacts on proteinuria and podocyte loss, the compound remains a cornerstone for those studying Calcium-permeable channels.
Interestingly, some investigations extend beyond simple inhibition. Recent stu Nonselective TRPC channel inhibition and suppression of … dies have touched upon its capacity to suppress aminoglycoside-induced premature termination codon readthrough. This reflects the multifactorial potential of small molecules when applied in controlled laboratory environments.
Best Practices and Experimental Vigilance
For AC1903: A Comprehensive Technical Guide to its Therapeutic … those planning to integrate this reagent into their experimental design, several considerations are paramount. Always refer to the provided technical documentation regarding AC1903 CAS 831234-13-0 to ensure the chemical identity matches your specific research intent. Given the potency of this compound, titration experiments are recommended to establish the optimal concentration for your specific model system—balancing efficacy with the need to avoid potential off-target toxicities.
The field of ion channel research continues to evolve, and compounds like AC1903 provide the precise, targeted control necessary to map the complex landscape of transient receptor potential channels. By adhering to rigorous experimental standards and sourcing from established suppliers, one can reliably utilize these tools to generate meaningful, reproducible data in a dedicated laboratory setting.